691 - 700 of 7785 Results
Title
Year
-
RESTRICTEDTitle: A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1493End Page: 1502Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29450Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29450Citation Count: 12
- Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?2023RESTRICTEDTitle: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2023.1197853/pdfCitation Count: 5
-
RESTRICTEDTitle: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathyJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 82Issue #: 6Start Page: 457End Page: 466Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlad026Citation Count: 6
- Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging Perspective2023RESTRICTEDTitle: Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging PerspectiveJournal Name: CellsPublisher: MDPI AGVol: 12Issue #: 11Start Page: 1469End Page: 1469Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells12111469Best OA location URL: https://www.mdpi.com/2073-4409/12/11/1469/pdf?version=1684979644Citation Count: 2
- Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkers2023RESTRICTEDTitle: Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 11Start Page: e95End Page: e97Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awad169Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad169/50433441/awad169.pdfCitation Count: 6
-
RESTRICTEDTitle: Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF PeriodsJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 4Start Page: 1033End Page: 1049Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-023-00486-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-023-00486-5.pdfCitation Count: 2
-
RESTRICTEDTitle: Longitudinal decline in striatal dopamine transporter binding in Parkinson’s disease: associations with apathy and anhedoniaJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 10Start Page: 863End Page: 870Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2022-330790Best OA location URL: https://jnnp.bmj.com/content/jnnp/early/2023/05/25/jnnp-2022-330790.full.pdfCitation Count: 8
-
RESTRICTEDTitle: Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S MutationsJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1541End Page: 1545Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29449Citation Count: 1
-
RESTRICTEDTitle: Association of sulfonylureas with the risk of dementia: A population‐based cohort studyJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 71Issue #: 10Start Page: 3059End Page: 3070Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/jgs.18397Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgs.18397Citation Count: 9
- Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s disease2023RESTRICTEDTitle: Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2023.1130833Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2023.1130833/pdfCitation Count: 4